These accomplishments signaled a halt in insulin product development until 1996, when the results of the Diabetic Control and Complication Trial (DCCT) and the United Kingdom Prospective Diabetic Study (UKPDS) were published, confirming the important role of glycemic control in preventing or delaying diabetes complications [6,7]. Here, INS is linked to diabetes mellitus.